Articles tagged with Stem Cell Research
Scientists at UCI created an eight-layer, early-stage retina from human embryonic stem cells, a complex tissue structure that could lead to transplant-ready retinas for treating eye disorders. The breakthrough uses differentiation technique to create multiple cell types necessary for the retina, mimicking early-stage retinal development.
Rensselaer Polytechnic Institute has been awarded a four-year $2.45 million grant from the New York Stem Cell Science Program to create an upstate center of excellence for basic stem cell research. The grant will be used to build sophisticated laboratories with high-throughput culture and imaging equipment, enhancing stem cell research...
Researchers used clinical-grade human mesenchymal stem cells (hMSCs) to treat ALI, restoring normal function of alveolar epithelial cells and reducing inflammatory cytokines. The study found that intravenous delivery of hMSCs was as effective as intrabronchial administration in repairing damaged lung tissue.
Researchers have identified a previously undiagnosed condition and treated it with a stem cell transplant, saving the patient's life. The key to unlocking the reason for the patient's symptoms was contracting a rare version of glandular fever.
Researchers discover a combination of drugs that effectively target stubborn leukemia stem cells, which often escape standard treatment and lead to disease relapse. The study supports clinical trials of HDACi in combination with tyrosine kinase inhibitors to eliminate leukemia stem cells in patients with CML.
Researchers at the University of Texas M. D. Anderson Cancer Center have successfully transplanted adult stem cells into injured hearts, improving pumping efficiency for a year in a mouse model. The study used innovative imaging techniques to track the stem cells' location and performance over time.
Researchers at Yale University have discovered that endometrial stem cells can repair brain cells damaged by Parkinson's disease, potentially treating women with the condition. The study, published in Journal of Cellular and Molecular Medicine, found that these stem cells can differentiate into dopamine-producing nerve cells.
A new study compares induced pluripotent stem (iPS) cells and embryonic stem cells in modeling fragile X syndrome, a genetic disorder. The research reveals that the two cell types behave differently in the disease model, with iPS cells not fully replicating the gene silencing process.
Researchers successfully transplanted endometrial stem cells into the brains of mice with a Parkinson-like condition, restoring partially dopamine levels. This finding raises the possibility of women serving as their own stem cell donors and banks being established for men and women with Parkinson's disease.
Researchers at PMH discovered that progesterone alters breast stem cells, a finding with significant implications for breast cancer risk. The study shows how hormones affect breast stem cells during the reproductive cycle, providing a new pathway to understanding cell growth leading to breast cancer.
The study found that embryonic stem cell metabolites have highly unsaturated structures compared to mature cells, and levels decrease as they mature. The researchers also discovered a pattern in the chemistry that mirrors the cells' increasing biological maturity.
UCI scientists Marian Waterman and Aileen Anderson receive grants totaling $2.6 million to study human stem cells for therapeutic use and biomedical innovation. The research will further understanding of how stem cells survive and remain pluripotent, potentially leading to breakthroughs in induced pluripotent stem cell therapies.
Weill Cornell researchers discovered a single gene, Slitrk5, responsible for OCD-like behaviors in mice. The genetically altered mice exhibited repetitive self-grooming and extreme anxiety, with altered brain functioning mirroring those seen in human OCD patients.
Researchers have successfully extracted stem cells from sections of vein removed for heart bypass surgery, which can stimulate new blood vessels to grow and potentially help repair damaged heart muscle after a heart attack. The discovery brings the possibility of 'cell therapy' for damaged hearts one step closer.
Researchers have identified the location of bone generating stem cells in mice and found factors that control their growth. The discovery opens up avenues for studying bone tumor formation and regenerating damaged or injured bone.
A physics strategy called resonant activation is being tested as a solution for antibiotic resistance, targeting dormant persister cells. The approach involves repetitive antibiotic treatment to accelerate sterilization of bacterial colonies.
Einstein will increase research space and recruit new stem cell scientists with the new facility expansion, focusing on four broad themes: stem cell biology, genetics, cancer stem cells, and translational stem cell research. The renovation is expected to create 150 new jobs and drive scientific innovation for multiple diseases.
The Rutgers Stem Cell Research Center has derived new human embryonic stem cell lines, addressing concerns of contamination in previously approved lines. The center also offers a training course for stem cell scientists, with over 100 trained researchers to date.
Researchers at UTHealth are developing new strategies to derive hematopoietic stem cells from pluripotent stem cells, which could potentially treat blood diseases. Additionally, they are exploring gene-corrected induced pluripotent stem cells for treating two pediatric lung diseases, Surfactant Protein B Deficiency and Cystic Fibrosis.
Researchers solve the decade-old mystery of fragile human embryonic stem cells by discovering two novel synthetic small molecule drugs that promote cell survival. The team also unravels the mechanisms behind e-cadherin's role in cell signaling, providing a new understanding of stem cell biology and paving the way for potential therapies.
A new clinical trial, IMPACT-CABG, evaluates the safety and efficacy of injecting stem cells into the hearts of patients undergoing coronary bypass surgery. The study aims to promote healing and regeneration of damaged heart muscle, offering a less invasive alternative to heart transplant.
Scientists have developed tissue-engineered grafts composed of adult stem cells that can replace synthetic vascular bypass grafts. The study found that these grafts prevented clotting and thickening of the graft wall, improving their effectiveness in treating peripheral artery disease and dialysis access grafting.
Researchers discover a commercially available supplement stimulates production of hematopoietic stem cells, repairing the body. The supplement increases levels of these cells in the blood over a two-week period, showing potential for treating conditions associated with low cell counts.
Researchers find random gene expression changes during early differentiation, but stability increases by a factor of 100 after nine generations. This discovery sheds light on the mechanisms behind epigenetic inheritance and its impact on stem cell research.
A study published in Cell Transplantation has found that using ICG to label human embryonic stem cell-derived cardiomyocytes substantially improves efforts to optically track stem cells after transplanting them into heart tissues. The labeling procedure did not impair the viability or functional integrity of the cells.
A team of researchers led by Dr. Christopher Fasano successfully derived floor plate tissue from human embryonic stem cells, a crucial signaling center in brain development. This achievement paves the way for better understanding of neurodegenerative diseases like Parkinson's.
Researchers have pinpointed a key molecular player to control mesenchymal stem cell development, which could lead to new therapies for bone and cartilage diseases. The study found that activating the Notch pathway can delay the development of these cells, potentially making them more useful for treating conditions like osteoporosis.
Researchers at Boston Children's Hospital discovered a possible way to kill off leukemia stem cells and prevent relapse. The study found that targeting the Wnt/beta-catenin pathway can suppress leukemia recurrence by inhibiting beta-catenin, a crucial player in leukemia stem cell development.
Scientists at Duke University Medical Center have discovered a new growth factor that stimulates the expansion and regeneration of hematopoietic stem cells. The growth factor, pleiotrophin, has been shown to increase the numbers of human cord blood stem cells in culture capable of engraftment in immune-deficient mice.
Researchers have discovered that infantile hemangiomas originate from stem cells. Steroids target these stem cells specifically, inhibiting their ability to stimulate blood vessel growth. This finding opens the way for more specific and safer therapies for hemangioma.
Researchers at Johns Hopkins School of Medicine have discovered a potential new treatment using bone marrow stem cells to build new blood vessels in the upper leg. The treatment, which uses X-ray-visible microbubbles to deliver stem cells, was shown to dramatically improve the body's ability to form new blood vessels and provide a more...
Researchers at USC identified retinoic acid, a derivative of vitamin A, as a critical regulator of the Second Heart Field's tissue formation and septation process. Disruptions in this pathway can result in serious congenital malformations of the heart.
UC Irvine researchers have sequenced the Hydra genome, discovering genes linked to Huntington's disease and beta-amyloid plaque formation in Alzheimer's. The genome sequencing advances research on regeneration, stem cells, and patterning, offering potential new treatments for various injuries and diseases.
The American Thoracic Society has released new guidelines for CCHS, citing crucial discoveries linking the condition to mutations in the PHOX2B gene. Affected individuals require fastidious medical supervision to attain optimal quality of life, and early identification and intervention are critical.
Researchers at Northwestern University characterized a special type of stem cell, endothelial progenitor cells (EPCs), to see if they can behave as endothelial cells in the body when cultured on a bioengineered surface. The study shows promise for improving surgery success rates for peripheral arterial disease.
A study published in the Journal of Cerebral Blood Flow & Metabolism found that repeated anesthesia can cause a significant decrease in stem cells in the hippocampus, leading to impaired memory and learning in young animals. The researchers believe this effect may be age-related, with younger animals being more susceptible.
Researchers discovered endothelial cells can grow copious amounts of adult stem cells and their progeny over weeks, revolutionizing organ regeneration and cancer cell growth inhibition. This vascular-cell model could manufacture unlimited blood-related stem cells for transplantation.
Researchers at M. D. Anderson Cancer Center developed a new assessment tool to measure the severity of chronic graft-versus-host disease (cGVHD) symptoms, which can complicate stem cell transplantation. The tool, MDASI-cGVHD, assesses symptoms on a scale of zero to 10 and correlates with patient reports of overall quality of life.
Scientists at Rhode Island Hospital have discovered a novel mechanism of cell-to-cell communication using microvesicles, which can reprogram stem cells to behave like healthy cells. This finding offers hope for tissue regeneration and potential treatments for diseases such as cancer.
Researchers at Columbia University Irving Medical Center successfully used mouse embryonic stem cells to replace diseased retinal cells and restore sight in a mouse model of retinitis pigmentosa. The study showed promising results, with one-fourth of the mice regaining vision after receiving the stem cells.
US government's lifting of restrictions on federally-funded stem cell research has helped scientists focus on science, but limitations remain. George Daley will discuss the current climate and potential of induced pluripotent stem cells (iPS) in treating devastating diseases.
A UCSF team recommends modifying NIH stem cell guidelines to protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization. The guidelines currently give IVF patients unrestricted authority over embryos leftover after fertility treatments.
Researchers at The Ottawa Hospital Research Institute have discovered that stem cells intentionally break and repair their own DNA as a mechanism of activating genes that promote tissue development. This novel process, crucial for muscle tissue development, may also be important for the development of most other tissues.
Clive Svendsen's team develops specifically-engineered stem cells that stall nerve cell degeneration in ALS patients. The award will fund novel ex vivo gene therapy approaches to treat the disease.
Researchers at UC San Diego have identified the region in vertebrates where adult blood stem cells arise during embryonic development. This discovery is a critical step towards developing safer and more effective stem cell therapies for patients with leukemia, multiple myeloma, and other diseases.
A clinical trial is underway to determine if infusing stem cells from umbilical cord blood can improve the lives of children with cerebral palsy. The study will include 40 children aged 2-12, who will receive either a real or placebo infusion of cord blood.
Researchers use minicircles to reprogram adult cells, achieving higher efficiency than viral vectors and introducing new hope for regenerative medicine applications. The discovery enables easier creation of induced pluripotent stem cells, which can be used to study human diseases and develop novel treatments.
Materials scientists at the University of Washington have developed a three-dimensional scaffold made from natural materials that mimic the binding sites for stem cells. Human embryonic stem cells grow and multiply readily on this structure, offering a clean and biodegradable alternative to traditional feeder layers.
The University of California, Riverside's new Stem Cell Core Facility will enable faster breakthroughs in stem cell research, targeting diseases such as osteoporosis and diabetes. The facility is equipped with the first-in-country Nikon BioStation CT technology, expected to provide valuable data for attacking degenerative diseases.
Researchers have successfully developed a new stem cell treatment that can arrest acute lung injury in mice, paving the way for potential treatments of respiratory diseases. The experimental treatment uses transplantable lung cells derived from human embryonic stem cells and has shown promising results in tests on mice with damaged lungs.
Researchers propose a model of adult stem cell regulation that explains how coexistence of quiescent and active stem cell populations supports tissue renewal and regeneration. The new model suggests separate functional roles for both sub-populations, which may also contribute to cancer drug resistance.
Shinya Yamanaka has developed a method to reprogram adult skin cells into pluripotent stem cells, eliminating the need for embryos. This breakthrough will aid research into preventing birth defects and improving baby health.
A study led by NYSCF Fellow Daylon James has generated a human embryonic stem cell line to measure and boost endothelial cell production, establishing a standard methodology for producing functional endothelial cells from hESCs. The cells can now be used for pre-clinical assessment of vascular disease in large animal models.
A study published in PNAS found that delivering stem cells on a polymer scaffold to treat large areas of missing bone leads to improved bone formation. However, the therapeutic effect is limited by the migration of stem cells away from the injury site, highlighting the need for improved delivery methods.
Scientists from University of Wisconsin-Madison present a new model of stem cell regulation in Caenorhabditis elegans, balancing stem cell maintenance and differentiation. The regulatory network defines two states - stem cell state and differentiated state - and regulates their balance.
Scientists at Queen Mary University of London have discovered that medulloblastomas, the most common type of children's brain cancer, can arise from a specific type of stem cell. This breakthrough finding may lead to new ways to tackle the disease and improve treatment outcomes for patients.
Chinese researchers have become a leading contributor to peer-reviewed scientific literature on clock-reversing regenerative medicine, with over 1,100 publications in 2008. New regulations aim to improve patient safety and restore China's global reputation.
Researchers found that MyoD activates CDC6 expression to promote rapid proliferation of muscle stem cells. The study suggests a new mechanism for muscle regeneration and highlights the importance of transcription factors in controlling cell cycle progression.
A recent study developed a straightforward technique to determine the ethnic origin of stem cells, finding that Caucasian and East Asian populations are overrepresented in current cell lines. The team created a new stem cell line with a West African Yoruba genetic profile, which could lead to more diverse research and safer therapies.
Researchers found that vitamin C accelerates gene expression changes and promotes efficient iPSC generation. The study suggests a simple way to improve iPSC production, which can be considered a reversal of the aging process at the cellular level.